Latest filingSep 04, 2026Most recent Form 4
ADXN
Addex Therapeutics Ltd.
Insider activity for last month from 08/04 to 09/04. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total buying$00 buys
Total selling$00 sells
Net open-market+$08 insiders
Open-market mix
Buy vs sell distribution by transaction countInsider activity report
Monthly open-market purchase and sale counts Buys Sells
Transaction codes
By Form 4 transaction code in selected period44transactions
- A · Grants / awards · dominant22 · 50%
- D · Issuer dispositions22 · 50%
Activity by reported role
A joint filing can contribute to multiple roles44transactions
- Director · dominant16 · 36%
- PAO16 · 36%
- Chief executive officer4 · 9%
- CMO4 · 9%
- HTS4 · 9%
Distinct insiders active
Reporting-owner CIKs by month · peak Sep 2026 (8)Aug 2026Sep 2026
Reported Holdings After
Separated by insider, security, and ownership typeTeyssedou Lenaic NathanaelStock-option (Right to Buy) · Direct
537,288Sep 02, 2026
Dyer Timothy MarkStock-option (Right to Buy) · Direct
0Sep 02, 2026
Dyer Timothy MarkCommon Stock · Direct
16,848,979Sep 02, 2026
Hill Raymond GeorgeStock-option (Right to Buy) · Direct
273,107Sep 02, 2026
Hill Raymond GeorgeCommon Stock · Direct
0Sep 02, 2026
Lawton Vincent MichaelCommon Stock · Direct
2,507,987Sep 02, 2026
Lawton Vincent MichaelStock-option (Right to Buy) · Direct
501,598Sep 02, 2026
Manke IsaacCommon Stock · Direct
0Sep 02, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells redAug 04 → Sep 04
LessMore
Filing detail checks
Secondary metrics for the selected periodFiling-only signals
Deterministic matches in the selected period
No filing-only signal badges matched this period.
ADXN transaction history
Filters apply within this company and selected period by default| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
No transactions match your filtersOnce the backend ingests and parses SEC filings, they will appear here. Try removing a filter or picking a wider date range. | ||||||||||
Addex Therapeutics Ltd. Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at Addex Therapeutics Ltd.?
Teyssedou Lenaic Nathanael, Kalinichev Mikhail, Nunn Jason Raleigh, Mills Roger, Manke Isaac, Lawton Vincent Michael, Hill Raymond George, Dyer Timothy Mark.
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
No code-S sale is available for this period.
What is the recent purchase and sale balance?
No code-P purchases or code-S sales were reported in the selected period.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.